Get the app
US › Healthcare

InnovAge Holding Corp (INNV)

US · Healthcare · Medical Care Facilities

$8.97-1.32%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$264.8M
Revenue YoY
+12.1%
Net profit
$19.6M
Profit YoY
+143.8%
EPS
$0.14
EPS estimate
$0.11
Net margin
7.4%

EPS came in at 0.14 against a street estimate of 0.11 — a beat of 27.3%.

Key statistics

Market cap
$1.34B
Forward P/E
13.7
P/B
5.16
Book value
$1.73
EPS (TTM)
$-0.02
52-week high
$12.64
52-week low
$4.17
50-day MA
$9.75
200-day MA
$9.10
Beta
0.19

Analyst view

Analysts rate InnovAge Holding Corp a hold (1 buy, 1 hold, 1 sell out of 3) with an average price target of $12.00.

From the latest earnings call · 2026-09-08

CONFIDENT InnovAge delivered 175% EBITDA growth in FY26 and is entering a scaled growth phase (InnovAge 3.0). FY27 guidance is inline with street; margin discipline prioritized as rate growth moderates. Quality and compliance remain non-negotiable. Q4 FY26 California and Colorado (70% of census) represent the largest concentration risk; final rate outcomes for both states pending as of call date. Call did not include analyst Q&A segment; Q&A portion was not transcribed or was not part of this earnings call excerpt. 2026-09-08…

Full summary in the app.

Shareholding

Insiders
74.90%
Institutions
15.06%

Largest institutional holders

FundStake
T. Rowe Price Investment Management,Inc.4.49%
Federated Hermes Inc1.40%
BlackRock Inc1.09%
Vanguard Capital Management, LLC0.69%
Arrowstreet Capital Limited Partnership0.49%
Algert Global LLC0.46%
Geode Capital Management, LLC0.44%
State Street Corp0.34%

Recent filings & reports

DocumentDate
Quarterly report · Q1 FY2027
HEADLINE NUMBERS • Total revenue was $264,757 thousand, up from $236,105 thousand in the three months ended September 30, 2025. • Operating income w
2026-11-03
Results announced · Q2 FY2027
HEADLINE NUMBERS • Fiscal first-quarter 2027 revenue was $264.8 million, up from $236.1 million in fiscal first-quarter 2026, an increase of approxim
2026-11-03
Proxy statement · Q2 FY2027
EXECUTIVE PAY • CEO total compensation and change: The provided excerpt does not include the executive compensation tables, so it does not disclose t
2026-10-22
Company announcement · Q1 FY2027
INNOVAGE HOLDING CORP. (INNV) - FORM 8-K SUMMARY HEADLINE NUMBERS • Secondary offering of 10,000,000 shares at $9.25 per share completed September 2
2026-09-24
Annual report FY2026
INNOVAGE HOLDING CORP. - FORM 10-K SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Participants served: 8,230 PACE participants as of June 30,
2026-09-09
Results announced · Q1 FY2027
INNOVAGE HOLDING CORP. - FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total revenues FY2026: $989.7 million, up 15.9% from $853.7 million FY2025 • N
2026-09-08
Reg FD disclosure · Q4 FY2026
INNOVAGE HOLDING CORP (INNV) - FORM 8-K SUMMARY HEADLINE NUMBERS • No specific financial metrics disclosed in this filing • Document is a Regulation
2026-05-18
Board / officer change · Q4 FY2026
INNOVAGE HOLDING CORP. (INNV) - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • InnovAge Holding Corp. appointed Jennifer Browne as President and C
2026-05-12

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InnovAge Holding Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.